Trial Profile
A Study to Evaluate Safety and Efficacy of PHX1149T in Subjects With Type 2 Diabetes Mellitus.
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Dutogliptin (Primary) ; Metformin; Thiazolidinediones
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Therapeutic Use
- 21 Apr 2010 Results of the 12-week phase IIb trial have been published in the journal Diabetes, Obesity and Metabolism, according to a Phenomix media release.
- 13 Apr 2010 An extension protocol (NCT01101945) has been registered on ClinicalTrials.gov. It is active, no longer recruiting.
- 13 Apr 2010 An extension protocol (NCT01101945) has been registered on ClinicalTrials.gov. It is active, no longer recruiting.